1Kyle Perrin,Mathew Williams,Meme Wijesinghe,et al.Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long-acting β-agonist inhaler therapy in asthma[J].Journal of Allergy and Clinical Immunology,2010,126(3):505-510.
3John Haughney,David Price,Neil C.Barnes,et al.Choosing inhaler devices for people with asthma:Current knowledge and outstanding research needs[J].Respiratory Medicine,2010,104(9):1237-1245.
8Luigi Allegra,Giovanni Cremonesi,Giuseppe Girbino,et al.Real-life prospective study on asthma control in Italy:Cross-sectional phase results[J].Respiratory Medicine,2012,106(2):205-214.
9Valérie Siroux,Anne Boudier,Jean Bousquet,et al.Phenotypic determinants of uncontrolled asthma[J].Journal of Allergy and Clinical Immunology,2009,124(4):681-687.
10Sally E.Wenzel,William W.Busse.Severe asthma:Lessons from the Severe Asthma Research Program[J].Journal of Allergy and Clinical Immunology,2007,119(1):14-21.
5Shilo L, Hadari R, Kovatz S, et al. Appropriateness of nitrate use in a general medicine population. Ann Pharmacother,2001,35 :1339-42.
6Okamoto MP,Nakahiro RK. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic. Pharmacotherapy, 2001,21 : 1337-1344.
7Huse DM,Roht LH,Alpert JS,et al. Physicians, knowledge,attitudes,and practice of pharmacologic treatment of hypertension. Ann Pharmacother ,2001,35 : 1173-1179.
8Verleden GM, De VP. Assessment of asthma severity and treatment by GPs in Belgium:an Asthma Drug Utilization Reseaw.h Study(ADUR).Respir Med ,2002 ,96 :170-177.
9Vermeire PA, Rabe KF,Soriano JB,et al. Asthma control and diffeaences in management practices across seven European countries. Respir Med,2002,96 : 142-149.
